BRCA1 and female reproductive organ cancer: In cases with mutations in BRCA, most of their gynecological cancers were developed inside the ovary, and patients with mutations in genes other than BRCA1/2 mutation in the BROV probands, their gynecological cancers were developed in either ovary or uterus (p value = .003) shown in Table 1.